Capsaicin Intake and Oral Carcinogenesis: a Systematic Review by Mosqueda Solís, Andrea et al.
e261
Med Oral Patol Oral Cir Bucal. 2021 Mar 1;26 (2):e261-8. Capsaicin intake and oral carcinogenesis
Journal section: Oral Medicine and Pathology
Publication Types: Review
Capsaicin intake and oral carcinogenesis: A systematic review
Andrea Mosqueda-Solís 1, Irene Lafuente-Ibáñez de Mendoza 2, José Manuel Aguirre-Urizar 2, Adalberto 
Mosqueda-Taylor 3
1 Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden
2 Stomatology II Department, University of the Basque Country (EHU), Leioa, Spain
3 Health Care Department, Autonomous Metropolitan University Xochimilco, Mexico City, Mexico
Correspondence:
Health Care Department






Background: Chili is the most heavily and frequently consumed spice, either as a flavouring or colouring agent, 
and it is also a major source of pro-vitamin A, vitamin E and C. The main capsaicinoid found in chili peppers is 
capsaicin. It has been demonstrated that capsaicin acts as a cancer-suppressing agent through its antioxidant and 
anti-inflammatory effects, by blocking several signal transduction pathways. Oral squamous cell carcinoma is 
one of the most prevalent cancer worldwide. It is noteworthy that in countries where populations of diverse ethnic 
groups co-exist, differences have been observed in terms of incidence of oral cancer. The variances in their diet 
could explain, at least in part, these differences. The objective of this systematic review is to explore if there is 
evidence of a possible relationship between capsaicin intake and the incidence of oral squamous cell carcinoma, 
and discuss such association.
Material and Methods: A bibliographical search was made in PubMed, Scopus and Web of Science databases, and 
finally 7 experimental studies were included; OHAT risk of bias tool was used to assess their quality.
Results: All the studies confirm that capsaicin is a chemopreventive agent that prevents the development of oral 
cancer, through inhibition of malignant cell proliferation and increase of apoptosis.
Conclusions: More human studies are needed in order to clarify the real link between consumption of chili (cap-
saicin) and the prevalence of oral cancer.
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Introduction
Peppers, chilis or Capsicum are versatile crops included 
in most daily diets, especially in some geographical ar-
eas like China, Mexico, Turkey and Indonesia (1). Cap-
sicum plants are tropic crops that grow better in hotter 
zones and chili peppers are the pungent fruits of various 
species of the Capsicum genus and members of the So-
lanaceae family (2).
Chili is the most heavily and frequently consumed 
spice, as a flavouring or colouring agent, and it is also 
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ferences. Eating chili peppers is a cultural tradition in 
Mexico and one of the most consumed foods included 
in their diet. In addition, Mexico holds one of the larg-
est annual production (3.28 MT) and consumption (2.33 
MT) of chili pepper (22); therefore, a high consumption 
of chili may be related to a low incidence of oral cancer.
The objective of this systematic review is to explore if 
there is evidence of a possible relationship between cap-
saicin intake and the incidence of oral squamous cell 
carcinoma, and discuss such association.
Material and Methods 
- Information sources and search strategy
The design of this study fulfils the PRISMA guidelines 
(23). We performed a systematic bibliographic research 
in PubMed (US National Gallery of Medicine), Web of 
Science and Scopus databases, whose strategy consist-
ed of different combinations of the following keywords: 
capsaicin, chili, capsazepine, “oral cancer,” “oral carci-
noma", "oral squamous cell carcinoma” and oscc (cap-
saicin AND "oral cancer”; capsaicin AND "oral carci-
noma"; capsaicin AND "oral squamous cell carcinoma"; 
capsaicin AND oscc; chili AND "oral cancer”; chili 
AND "oral carcinoma"; chili AND "oral squamous cell 
carcinoma"; chili AND oscc; capsazepine AND "oral 
cancer”; capsazepine AND "oral carcinoma"; capsaze-
pine AND "oral squamous cell carcinoma"; capsazepine 
AND oscc). All referenced articles were also screened 
for further manual inclusion. This review was not regis-
tered at any platform for systematic review.
- Inclusion and exclusion criteria
Using PICOs criteria (Table 1), in this review we address 
the relationship between capsaicin intake and oral carci-
nogenesis. PICO question was: oral cancer (population), 
treatment with capsaicin or analogues (intervention), 
oral cancer without exposure to capsaicin or analogues 
(comparison), to assess the effect of capsaicin in the devel-
opment of oral squamous cell carcinoma (outcome) (23).
The inclusion criteria for the articles were: 1) studies 
published up to April 2020, 2) studies written in English 
or Spanish, and 3) experimental studies (in vitro and in 
vivo). Meanwhile, exclusion criteria were: 1) previous 
reviews, 2) studies that did not investigate the oral car-
cinogenesis, and 3) studies that did not use capsaicin as 
therapeutic agent.
- Study selection and data extraction
The bibliographic research was performed by two inde-
pendent reviewers (AMS and ILIM). All titles and ab-
stracts that met the search criteria were red and then, the 
potentially eligible articles were analysed for their inclu-
sion. Any disagreement between them was solved by a 
third and fourth reviewer (AMT or JMAU) to minimize 
bias of inclusion. Data from the included studies was 
collected by two reviewers (AMS and ILIM) and cross-
checked by another (AMT or JMAU) to guarantee integ-
a major source of pro-vitamin A (carotene), vitamin E 
(α-tocopherol) and vitamin C (ascorbic acid) (3). Ma-
ture pepper fruits are rich in carotenoids with antioxi-
dant properties and have high contents of phenolics, 
especially flavonoids; in addition, there are reports that 
mention that they have antioxidant and other bioactive 
properties, as well as many essential nutrients such as 
capsaicinoids (4-5). Capsaicinoids comprise a distinc-
tive group of molecules in fruits and plants, which dis-
play potentially valuable pharmacological and bioactive 
properties (6). Capsaicin (trans-8-methyl-N-vanillyl-
6-nonenamide) is the main capsaicinoid found in chili 
peppers (7).
In addition to its use as a major spice and food addi-
tive, capsaicinoids have also been used for medical and 
therapeutic reasons (8-9). It has been demonstrated 
that capsaicin also acts as a cancer-suppressing agent 
through its antioxidant and anti-inflammatory effects, 
by blocking several signal transduction pathways, in-
cluding Nf-kB and AP-1 (10-11).
Cancer is a major global public health problem; accord-
ing to World Health Organization (WHO) it is the second 
leading cause of death globally (12). The association be-
tween poor nutrition and cancer is increasingly evident, 
and following a healthy diet is a key lifestyle change to 
reduce its role as a cancer risk factor. Therefore, inter-
ventions to reduce smoking, improve diet and increase 
physical activity must become much higher priorities in 
the general population’s health and health care systems 
(13). Furthermore, the intake of specific foods like to-
matoes, citric fruits, olive oil, berries, honey, tea, aloe 
vera or curcuma contain active components that can in-
fluence the initiation and progression of carcinogenesis, 
and could act favourably on pathways implied in cell 
proliferation, apoptosis and metastasis (14-16).
Oral squamous cell carcinoma (OSCC) is one of the 
most prevalent cancer worldwide (incidence rate: 4 per 
100.000 worldwide), and accounts for 90% of all ma-
lignancies of the oral cavity (17). Main risk factors of 
OSCC are tobacco and alcohol consumption, human 
papillomavirus infection and presence of oral potential-
ly malignant disorders (18). Moreover, although treat-
ments have improved over the years, prognosis of oral 
cancer is still poor (19).
It is noteworthy that in countries where populations of 
diverse ethnic groups co-exist, differences have been 
observed in terms of incidence of oral cancer (20). In 
this regard, when comparing between countries, the in-
cidence rate of oral cancer in Mexico is 1.5, while in 
the USA it is much higher [4.3] (21), similar to what has 
been found when classifying by race and ethnicity in the 
later, where the rate of new cases of oral cancer is lower 
in Hispanics [4.62], including Mexicans, as compared 
to white people [9.53] (22). Diet could be considered as 
a possible factor to explain, at least partly, these dif-
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performance criteria were not reported by the authors; 
however, these items were not relevant and did not mod-
ify the overall risk of bias assessment.
Results
- Bibliographical research
We identified 98 records in the initial database search, 
out of which 73 were eliminated because were dupli-
cates. After the first screening, another 4 records were 
excluded because they did not study oral squamous cell 
carcinoma and 5 more because they did not investigate 
about capsaicin. Thus, only 16 records were eligible 
for analysis; of these, 5 previous reviews were also re-
moved, as well as 2 other studies that did not use cap-
saicin as therapeutic agent, and 3 that did not study the 
role of capsaicin in oral carcinogenesis. At the end, we 
added 1 article through manual research leaving the fi-
nal number in 7 studies selected for the systematic re-
view (6,25-30). Main data of the studies are shown in 
Table 2. The flowchart of the selection process is pre-
sented in Fig. 1.
rity of contents.
The information extracted from each study was: the au-
thor and year of publication, type of oral squamous cell 
carcinoma model (cell line and animal), number of cases, 
type of capsaicin intake, effect of capsaicin intake on oral 
carcinogenesis (incidence of epithelial dysplasia and oral 
cancer, epithelial-mesenchymal transition, cell prolifera-
tion, cell invasiveness, cell migration, apoptosis, chemo-
prevention, etc.).
- Risk of bias and quality assessment of the studies
OHAT Risk-of bias tool was used, for both in vitro and in 
vivo studies, to evaluate their methodological quality (24). 
OHAT risk of-bias rating is an effective approach that 
evaluates 11 different domains and 5 types of bias (selec-
tion, performance, attrition/ exclusion, detection and se-
lective reporting). The system for answering each ques-
tion requires reviewers to choose between definitely low/ 
probably low/ probably high/ definitely high risk of bias.
In general, the methodological quality of the studies 
was good, and OHAT tool showed that risk of bias was 
probably low (24). Some questions of the selection and 
Table 1: PICO criteria (participants/population, interventions, comparisons, outcomes, study design).
Table 2: Main data of the included studies.
Authors and year OSCC model Capsaicin/ Capsazepine/ Analogues
Tanaka et al. 2002 in vivo (4-weeks old F344 male rats, 4‐NQO) capsaicin (500 ppm): 1 and 18 weeks
Ip et al. 2010 in vitro (SCC-4 cell line) capsaicin (150, 200, 250, 300, 350 µM): 12, 24, 36, 48 h
Gonzales et al. 2014 in vitro (SCC4, SCC25, HSC3 cell line); in vivo (Athymic nude mice, HSC3, SCC4, SCC25 cells)
in vitro: CPZ (30μM), capsaicin (150 μM) 24h; 
in vivo: CPZ (1 μg/μl) 24h
De la Chapa et al. 2019a in vitro (Cal-27, SCC-4, SCC-9 cell lines); in vivo (Sprague-Dawley rats, Cal-27 cells)
in vitro: CIDD-99 (1–10μM), CIDD-111 
(2.5–40μM), CIDD-24 (20–30μM), CIDD-99 
(1–7.5μM); in vivo: CPZ, CIDD-24, CIDD-111 
(120μg), CIDD-99 (120, 240μg)
De la Chapa et al. 2019b in vitro (HSC-3 cell line) CPZ analogue 17 (20 µM), 29 (2µM): 24h
Kamaruddin et al. 2019 in vitro (ORL-48 cell line) capsaicin (50, 100, 150, 200, 250, 300, 350 µM): 24, 48, 72 h
Mohammed and AlQarni, 
2019 in vivo (Golden Syrian hamsters, DMBA) capsaicin (10 ppm)
4-NQO: 4-Nitroquinoline 1-oxide; CPZ: capsazepine; DMBA: 7,12-dimethylbenz(a)anthracene; OSCC: oral squamous cell carcinoma.
Parameter Inclusion criteria Exclusion criteria
Population Studies published until April 2020, studies written 
in English or Spanish, experimental studies (in vitro 
and in vivo) and clinical trials
Previous reviews, studies that didn’t investigate 
the oral carcinogenesis, studies that don’t use 
capsaicin as therapeutic agent, personal opinions, 
protocol letters, posters, conference abstracts
Intervention in vivo and in vitro models of OSCC with capsaicin 
(or analogues) intake
Comparison in vivo and in vitro models of OSCC with capsaicin 
(or analogues) intake 
in vivo and in vitro models of OSCC with intake 
of other drugs
Outcome
Find the association between the intake of capsa-
icin, and its analogues, in oral carcinogenesis
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- Individual studies
Three of the 7 studies included in our analysis were in 
vitro (25,28-29), 2 in vivo (6,30) and 2 both in vitro and 
in vivo (26-27).
In vitro studies
Ip et al. (25) were the first to study whether different 
doses of capsaicin could induce apoptosis in tongue 
cancer cells. They observed that 300 µM capsaicin de-
creased the levels of mitochondrial membrane potential 
(calcium influx) and increased the reactive oxygen spe-
cies (ROS). An increase of AIF, cytochrome c, active-
caspase-9, Bax, CHOP, Fas and active-caspase-8, and a 
decrease of pro-caspase-3 and Bid was also seen, all of 
which led to apoptosis. In addition, 350 µM capsaicin 
also decreased the percentage of viable cells, due to ar-
rest of cell cycle at G0/G1 stage (dose-dependent); and 
400 µM capsaicin induced DNA condensation, damage 
and fragmentation.
De la Chapa et al. (28) developed potent analogues based 
upon capsazepine (CPZ) pharmacophore and structure-
activity relationships (SAR) across analogues. Two of 
these, at different doses, had significant anti-prolifera-
tive effects in oral cancer cells.
Kamaruddin et al. (29) also investigated the apoptotic 
effect of capsaicin on human oral cancer cells. They 
saw that increasing concentrations of capsaicin were 
more cytotoxic to malignant cells. Capsaicin-induced 
apoptosis occurred through the shift in cell population 
from early apoptosis (24 h) to late apoptosis (48 and 72 
h). It also increased the activity of caspase-3-7-9 and 
mitochondrial membrane potential. Therefore, a lower 
percentage of viable malignant cells was seen in capsa-
icin treated cells after G1-phase, in comparison to con-
trol cells. These results indicated that cell cycle arrest of 
capsaicin-treated cells is associated with the antiprolif-
erative effect in a time-dependent manner.
In vivo studies
The effects of dietary administration of oral capsaicin 
on an animal tongue cancer model was firstly investi-
gated by Tanaka et al. (6). These authors demonstrated 
a lower incidence of oral epithelial dysplasia (OED) and 
carcinoma in capsaicin-treated rats. Apoptotic index 
(ssDNA) was higher in the capsaicin group, while pro-
liferative index (PCNA) was lower.
Fig. 1: PRISMA flowchart. Synthesis of the bibliographical analysis.
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Mohammed and AlQarni (30) also investigated the anti-
proliferative effect of capsaicin in OED and carcinogen-
esis. Capsaicin treated animals had a lower incidence 
and severity of OED (lower immunoexpression of Bcl-2).
In vitro and in vivo studies
Gonzales et al. (26) tested diverse cell lines with dif-
ferent doses of CPZ and capsaicin. An 80% reduction 
in cell viability was observed with CPZ and capsaicin 
together. Capsazepine also induced apoptotic activity 
(accumulation of subG1 cells, increase of ROS and c-
PARP) to all OSCC cell lines, even at low doses (30 
μM). However, this effect changed among cell lines, 
with more HSC3 and SCC25 cells in apoptosis (30 μM) 
or cell death (60 μM), than SCC4 cells at the same con-
centrations. These authors (26) also carried out an in 
vivo experiment with mice, and they found that CPZ 
treated HSC3 tumours did not enlarge as much as con-
trol group, and dramatically shrank in size, similar to 
SCC25 tumours, which displayed a marked reduction in 
tumour volume following treatment with CPZ (50.5%). 
In contrast, SCC4 control xenograft tumours grew near-
ly two-fold greater than CPZ treated cases, and showed 
more apoptotic figures.
De la Chapa et al. (27) demonstrated the apoptotic ef-
fect of both CPZ and CPZ analogs on various malignant 
cells by means of S-phase block, mitochondrial dys-
function and ROS-mediated c-PARP increase. CIDD-
99 (500 μM) also caused an anti-proliferative effect 
against Cal-27 cells when used with cisplatin, gefitinib, 
and radiation. The efficacy of these analogues was also 
assessed in vivo, all of which reduced tumour volume. 
Furthermore, in analog CIDD-99 treated rats, there 
were even no tumour cells remaining in some cases.
Discussion
Oral carcinogenesis involves a series of steps which are 
controlled by many factors, including genetic, metabol-
ic and environmental ones. About 30-35% of carcino-
mas are initiated due to dietary factors (31); however, 
many types of compounds have also been studied as 
chemopreventive agents.
The link between capsaicin and cancer has long been 
studied (32). Initial investigations suggested that con-
tinuous intake of capsaicin increased the risk to develop 
some carcinomas of the digestive tract, including gas-
tric cancer. However, it was later discovered that cap-
saicin might act, in fact, as a chemopreventive agent, 
altering the microsomal function of several enzymes, 
which are key for the metabolic activation and detoxifi-
cation of multiple mutagens.
The first authors who reported the anticarcinogenic 
properties of capsaicin were Modly et al. (33), who in-
dicated that this substance inhibited the metabolism of 
many polycyclic aromatic hydrocarbons like benzo(a)
pyrene 3 and suppressed their binding to human DNA. 
Many studies have proven that this effect is obtained 
through the modulation of cytochrome P450 and 
NADPH dependent activities (34).
New discoveries have been made in the last years re-
garding the antiproliferative and apoptotic effect of cap-
saicin on human colon and oesophageal carcinoma (35). 
It has been demonstrated that capsaicin supresses both 
intrinsic and extrinsic tumour signalling pathways, 
which are necessary for the invasion and migration of 
malignant cells (36).
It is of great interest to know the specific effect of this 
compound on carcinomas of the upper aerodigestive 
tract. Previous studies (37-38) have proven that cap-
saicin supresses the growth of gastric cancer through 
downregulation of several pathways (NADPH, ERK 
1/2, p38 MAPK, JNK), inhibition of inflammatory 
molecules (IL-6) and increase of apoptotic molecules 
(caspase-3, p53). On the other hand, capsaicin also in-
duces G1 arrest and apoptosis of nasopharyngeal cancer 
cells through mitochondrial depolarization and acting 
on specific pathways (PI3K/mTOR) and molecules (cas-
pase-3, Bcl-2) (39). In addition, it retrains the invasion 
and migration of malignant oesophagus cells by inhibi-
tion of MAPK signalling pathway, intracellular stress 
and promotion of p53 (40).
The reason behind this review was to acknowledge the 
link between capsaicin and oral cancer (8). Previous 
studies showed molecular evidences of oral cell prolif-
eration inhibition associated to other compounds, such 
as lycopene, green tea polyphenols, resveratrol and cur-
cumin (41). Apoptosis of oral malignant cells has also 
been related to lycopene, quercetin, epigallocatequin 
gallate, theaflavin-3 gallate, garlic and ginger (42-43).
According to our search, all the studies included in this 
review (6,25-30) confirm that capsaicin must be consid-
ered as a chemopreventive agent for oral cancer (Fig. 
2) check Supplement 1 (http://www.medicinaoral.com/
medoralfree01/aop/24570_supplement1.pdf). Since the 
original report, it was suggested that continuous intake 
of capsaicin decreased the incidence of oral cancer, be-
cause it stopped the proliferative activity of malignant 
cells and increased their apoptosis (6). Moreover, differ-
ent studies have observed a reduction on tumour size in 
mice treated with CPZ (26), and even absence of malig-
nant cells in rats treated with CPZ (27).
This cytotoxic effect of capsaicin has been demonstrated 
and reinforced with different techniques throughout the 
years, and it seems to be time and dose dependent; how-
ever, since low doses of capsaicin continue to be chemo-
preventive, multiple in vitro studies have been carried 
out in order to uncover its molecular mechanisms. Ip et 
al. (25) pointed out that capsaicin induces G0/G1 cell 
cycle arrest and apoptosis in SCC-4 cells, through an 
increase of ROS, Ca2+ and caspase-9. Also, it produces 
the overexpression of several molecules of cellular stress 
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that lead to apoptosis (AIF, cytochrome c, Bax, CHOP, 
Fas). The same apoptotic pathway was observed by 
Kamaruddin et al. (29), with less viable cells after G1-
phase in the capsaicin treated group, due to an increase 
of caspases and mitochondrial depolarization, and also 
similar results were found by de la Chapa et al. (27), 
who reported an increase of ROS-mediated c-PARP.
It is noteworthy that, in spite of using different cell 
lines, capsaicin doses and duration of treatments, both 
capsaicin and CPZ trigger the same alterations on the 
malignant cells. We consider that these results indicate 
that the antiproliferative effect of capsaicin could be 
linked to apoptosis. Interestingly, some studies showed 
that CPZ has a stronger cytotoxic activity than capsa-
icin, since more cells underwent apoptosis and showed 
phenotypic changes (26). Furthermore, CPZ without 
capsaicin also decreases cell proliferation and tumour 
size, and even promotes the effect of chemo and radio-
therapy (27-28).
Another aspect of great interest is the link between cap-
saicin and OED (6,30). To date, histopathological analy-
sis is the gold standard technique to make a diagnosis of 
oral cancer, while presence of OED represents the key 
prognostic factor to predict malignant transformation 
of a lesion in the oral mucosa; thus, its recognition and 
graduation is very important for primary and second-
ary prevention of oral cancer. In this sense, Tanaka et 
al.(6) found that capsaicin-treated animals had a lower 
incidence of OED, which later Mohammed and AlQarni 
(30) proved to be related to a lower immunoexpresion of 
anti-apoptotic biomarker Bcl-2.
Considering all the available information, we believe 
dietary consumption of capsaicin could provide a che-
mopreventive effect for oral squamous cell carcinoma. 
We think this protective property may explain why the 
incidence of oral cancer upon chili consumers is lower. 
In fact, peppers cover 1.93 million ha of crop-growing 
surface areas worldwide, and Mexico is the second larg-
est pepper producer in the world (2.3 million) (1). Thus, 
intake of capsaicin is an important sociocultural ele-
ment in some populations. Although indirectly, there is 
epidemiological evidence suggesting that the protective 
effect of capsaicin could be responsible, at least partial-
ly, for the disparities observed in the incidence of oral 
cancer among different ethnic groups living in the same 
population, such as the USA, where the rate of new cas-
es of oral cancer is significantly lower in Hispanics than 
in white people (21) (Fig. 3).
Nevertheless, more studies are needed to further un-
derstand the mechanism by which these compounds 
prevent oral carcinogenesis, and to develop novel thera-
peutic agents for clinical application against oral cancer.
Conclusions
In summary, this study gives a comprehensive view of 
the relationship between capsaicin and oral carcinogen-
esis. Both capsaicin and capsazepine are chili substanc-
es that may prevent the development of oral epithelial 
dysplasia and oral squamous cell carcinoma. The steps 
in which these compounds could have a chemopreven-
tive activity against oral cancer are: inhibition of ma-
lignant cell proliferation and increase of malignant cell 
apoptosis. These findings elucidate why dietary intake 
of capsaicin could explain the existing differences in 
the prevalence of OSCC in certain world populations. 
Future research should focus on humans, to investigate 
the relationship between consumption of specific foods 
such as chili (capsaicin) and the prevalence of oral can-
cer, through well-designed studies (patient-clinician 
communication, food frequency questionnaires, etc.).
Fig. 2: Oral carcinogenesis processes in which capsaicin/capsazepine/analogues may be implicated.
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